NCT00403949

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

A 6-week, Vehicle-controlled, Randomized, Double-blind, Parallel-group Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Perioral Dermatitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: LEO Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to test the efficacy and safety of AzA 15% Gel in the treatment of mild to moderate perioral dermatitis.

Conditions

• Perioral Dermatitis

Interventions

Type	Name	Description
DRUG	Azelaic acid 15% gel	gel, applied once daily, for 6 weeks
DRUG	Non-active base from azelaic acid 15% gel	gel, apply once daily for six weeks

Timeline

• Start date: 2006-11-01
• Primary completion: 2007-03-01
• Completion: 2007-03-01
• First posted: 2006-11-27
• Last updated: 2023-06-09

Locations

4 sites across 1 country: Germany